ANTI-IL2 RECEPTOR GAMMA ANTIGEN-BINDING PROTEINS
- 专利权人:
- Regeneron Pharmaceuticals; Inc.
- 发明人:
- Jamie M. Orengo,Andrew J. Murphy
- 申请号：
- US16776928
- 公开号：
- US20200247894A1
- 申请日:
- 2020.01.30
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention provides antibodies and antigen-binding fragments (e.g., human antibodies) that bind specifically to human IL2 receptor gamma (IL2Rγ). Methods for treating or preventing diseases mediated by IL2Rγ (e.g., graft vs host disease) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Humanized Antibody that binds to the receptor Alpha Chain (IL - 7 Human disorders)； Protein Binding to Antigen that includes one or more complementarity determining regions of the anticuBody； Nucleic Acid Molecule that encodes a Protein of Antibody or link； expression vector；Recombinant host Cell； procedure for the production of a Protein Binding to Antigen； procedure for treating inflammatory or Autoimmune Disease.
- HUMAN RESISTIN COMPOSITIONS AND METHODS OF TREATING TLR4-MEDIATED DISEASE AND INFECTION
- ANTI-CD26 ANTIBODIES AND USES THEREOF
- isolated antibodies, isolated nucleic acid, host cell, methods of producing an antibody, treating cancer, treating a disease and detecting human jagged1 in a biological sample, immunoconjugate, pharmaceutical formulation and antibody use
- HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR
